
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.010 | 53.640 | 48.630 |
Shares | 94.090 | 94.090 | 0.000 |
Bonds | 0.060 | 0.070 | 0.010 |
Other | 0.830 | 0.830 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.560 | 19.680 |
Price to Book | 3.223 | 3.883 |
Price to Sales | 1.652 | 2.233 |
Price to Cash Flow | 12.583 | 14.780 |
Dividend Yield | 2.860 | 1.493 |
5 Years Earnings Growth | 9.536 | 9.837 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 49.630 | 94.326 |
Financial Services | 23.530 | 7.445 |
Consumer Cyclical | 15.870 | 6.754 |
Consumer Defensive | 3.580 | 3.041 |
Real Estate | 2.890 | 1.230 |
Technology | 2.610 | 5.296 |
Industrials | 1.900 | 3.309 |
Number of long holdings: 145
Number of short holdings: 92
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Manulife Financial | CA56501R1064 | 3.04 | 30.74 | +2.26% | |
MetLife | US59156R1086 | 3.03 | 81.49 | +2.84% | |
Legal & General | GB0005603997 | 2.95 | 256.50 | +0.83% | |
Novo Nordisk B | DK0062498333 | 2.86 | 363.9 | +2.19% | |
SCI | US8175651046 | 2.78 | 81.50 | +0.33% | |
BlackRock | US09290D1019 | 2.66 | 1,148.17 | +2.08% | |
Eli Lilly | US5324571083 | 2.65 | 711.68 | +0.26% | |
Boston Scientific | US1011371077 | 2.45 | 106.17 | +0.91% | |
Apple | US0378331005 | 2.45 | 227.76 | +1.27% | |
Amundi Euro Liquid Shrt Trm SRI Z C | FR0014005XL2 | 2.42 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1903290036 | 3.16B | -0.01 | 10.44 | - | ||
LU1530900684 | 3.16B | -4.98 | 8.19 | - | ||
LU1530899142 | 3.16B | -5.48 | 7.14 | - | ||
LU2035461495 | 3.16B | -5.20 | 7.49 | - | ||
LU1902444402 | 1.82B | -0.31 | 7.14 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review